
S&P 500 Pushes for 9th Straight Day of Gains, Eli Lilly Says Weight-Loss Drug Reduces Diabetes Risk
The Rundown
00:00
Intro
This chapter explores the current positive trends in the stock market, with a focus on the S&P 500 and NASDAQ’s performance, particularly Nvidia's stock. It also addresses mixed earnings from Lowe's and the significant news of Eli Lilly's promising weight-loss drug, Zepbown, while contemplating potential shifts in the market due to interest rates.
Transcript
Play full episode